APPLICATIONS NOW BEING ACCEPTED
APPLICATIONS NOW BEING ACCEPTED Actelion ENTELLIGENCE™ Young Investigator Program ENTELLIGENCE™ www.entelligencemd.org
Established in 2005, the ENTELLIGENCE Young Investigator Program is a US-based research program consistent with Actelion Pharmaceutical US, Inc.’s commitment to basic science, translational, and clinical research in the area of pulmonary vascular disease. Young investigators at universities and research institutes in the United States and Canada with innovative projects and promising careers in pulmonary vascular disease are supported by the ENTELLIGENCE program.
ENTELLIGENCE Steering Committee (SC) Ronald J. Oudiz, MD Program Chairman LA Biomedical Research Institute at Harbor-UCLA Medical Center Torrance, CA
Award winners receive a research grant of up to $100,000 to fund a 1-year mentored project.
Harrison W. Farber, MD
Boston University School of Medicine Boston, MA Adaani E. Frost, MD Baylor College of Medicine Houston, TX Mardi Gomberg-Maitland, MD, MSc University of Chicago Medical Center Chicago, IL Maureen D. Mayes, MD, MPH The University of Texas Health Science Center at Houston Houston, TX Evangelos D. Michelakis, MD University of Alberta Edmonton, AB, Canada Harold I. Palevsky, MD Perelman School of Medicine of the University of Pennsylvania Philadelphia, PA Richard M. Silver, MD Medical University of South Carolina Charleston, SC
ENTELLIGENCE Milestones • • • •
Year established: 2005 Review cycles completed: 9 Awards distributed: 46 Funding: $3,825,000
2014-2015 Timeline •
Letter of Intent (LOI) Submission: Sept. 18 – Nov. 6, 2014
•
LOI Review: Nov. 10 – Dec. 5, 2014
•
Grant Submission: Dec. 16, 2014 – Feb. 2, 2015
•
Grant Review: Feb. 4 – 23, 2015
•
SC Selection Meeting: March 2, 2015
•
Notify Applicants: March 23, 2015
Jason X-J Yuan, MD, PhD University of Arizona College of Medicine Tucson, AZ Please visit www.ENTELLIGENCEMD.org for more information and to apply. The Actelion ENTELLIGENCE Young Investigator Program is supported through an educational grant from Actelion Pharmaceuticals US, Inc.
Established in 2005, the ENTELLIGENCE Young Investigator Program is a US-based research program consistent with Actelion Pharmaceutical US, Inc.’s commitment to basic science, translational, and clinical research in the area of pulmonary vascular disease. Young investigators at universities and research institutes in the United States and Canada with innovative projects and promising careers in pulmonary vascular disease are supported by the ENTELLIGENCE program.
ENTELLIGENCE Steering Committee (SC) Ronald J. Oudiz, MD Program Chairman LA Biomedical Research Institute at Harbor-UCLA Medical Center Torrance, CA
Award winners receive a research grant of up to $100,000 to fund a 1-year mentored project.
Harrison W. Farber, MD
Boston University School of Medicine Boston, MA Adaani E. Frost, MD Baylor College of Medicine Houston, TX Mardi Gomberg-Maitland, MD, MSc University of Chicago Medical Center Chicago, IL Maureen D. Mayes, MD, MPH The University of Texas Health Science Center at Houston Houston, TX Evangelos D. Michelakis, MD University of Alberta Edmonton, AB, Canada Harold I. Palevsky, MD Perelman School of Medicine of the University of Pennsylvania Philadelphia, PA Richard M. Silver, MD Medical University of South Carolina Charleston, SC
ENTELLIGENCE Milestones • • • •
Year established: 2005 Review cycles completed: 9 Awards distributed: 46 Funding: $3,825,000
2014-2015 Timeline •
Letter of Intent (LOI) Submission: Sept. 18 – Nov. 6, 2014
•
LOI Review: Nov. 10 – Dec. 5, 2014
•
Grant Submission: Dec. 16, 2014 – Feb. 2, 2015
•
Grant Review: Feb. 4 – 23, 2015
•
SC Selection Meeting: March 2, 2015
•
Notify Applicants: March 23, 2015
Jason X-J Yuan, MD, PhD University of Arizona College of Medicine Tucson, AZ Please visit www.ENTELLIGENCEMD.org for more information and to apply. The Actelion ENTELLIGENCE Young Investigator Program is supported through an educational grant from Actelion Pharmaceuticals US, Inc.
